We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$325M
AUM Growth
–
Cap. Flow
+$311M
Cap. Flow %
95.96%
Top 10 Hldgs %
23.82%
Holding
94
New
93
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
MDVN
MEDIVATION, INC.
MDVN
+$8.15M
2
PCYC
PHARMACYCLICS INC
PCYC
+$8.08M
3
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
+$8.06M
4
DYAX
DYAX CORPORATION
DYAX
+$7.87M
5
CBI
Chicago Bridge & Iron Nv
CBI
+$7.84M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 21.71%
2 Consumer Discretionary 15.26%
3 Industrials 10.39%
4 Energy 7.87%
5 Technology 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TLPH icon
76
Talphera
TLPH
$70.1M
$599K 0.18%
+2,650
New +$461K
INSM icon
77
Insmed
INSM
$22B
$560K 0.17%
+32,900
New +$504K
TFX icon
78
Teleflex
TFX
$5.86B
$544K 0.17%
+5,800
New +$532K
BLUE
79
DELISTED
bluebird bio
BLUE
$539K 0.17%
+1,984
New +$554K
ATHN
80
DELISTED
Athenahealth, Inc.
ATHN
$538K 0.17%
+4,000
New +$514K
FEIC
81
DELISTED
FEI COMPANY
FEIC
$536K 0.17%
+6,000
New +$532K
RPTP
82
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$526K 0.16%
+40,400
New +$556K
MDAS
83
DELISTED
MEDASSETS INC COM STK (DE)
MDAS
$525K 0.16%
+26,500
New +$596K
MGNX icon
84
MacroGenics
MGNX
$240M
$521K 0.16%
+19,000
New +$497K
LITS
85
Lite Strategy Inc
LITS
$33.6M
$497K 0.15%
+3,105
New +$531K
ECYT
86
DELISTED
Endocyte, Inc. Common Stock
ECYT
$489K 0.15%
+45,700
New +$505K
RMD icon
87
ResMed
RMD
$30.3B
$466K 0.14%
+9,900
New +$501K
ATHX
88
DELISTED
Athersys, Inc. Common Stock
ATHX
$443K 0.14%
+7,084
New +$338K
VIRX
89
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$435K 0.13%
+437
New +$452K
NBIX icon
90
Neurocrine Biosciences
NBIX
$18.7B
$360K 0.11%
+38,500
New +$376K
HTWR
91
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$291K 0.09%
+3,100
New +$262K
FMI
92
DELISTED
Foundation Medicine, Inc.
FMI
$274K 0.08%
+11,500
New +$321K
TRAW icon
93
Traws Pharma
TRAW
$6.72M
– –
0
– –
VVUS
94
DELISTED
Vivus Inc
VVUS
$253K 0.08%
+2,790
New +$269K
1 2 3
4

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q4 2013 Portfolio in Review

Q4 2013 is the first quarter with a 13F filing on record for Eventide Asset Management, which disclosed 94 positions worth $325M. Its ten largest holdings account for 24% of the portfolio.

Its largest position is MEDIVATION, INC.: 269,600 shares worth $8.6M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, followed by Consumer Discretionary and Industrials.

  • Eventide Asset Management's largest Q4 2013 buy was MEDIVATION, INC.: 269,600 shares worth $8.6M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $325M portfolio in Q4 2013.
  • Eventide Asset Management disclosed 94 positions in Q4 2013, its first 13F filing on record.

Based on Eventide Asset Management's 13F filing for Q4 2013, filed 11 Feb 2014.